Page last updated: 2024-08-23

pirfenidone and Asthma

pirfenidone has been researched along with Asthma in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's2 (40.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Abdelmoneim, AM; Alanazi, MM; Baioumy, B; El-Shafey, RS; Elshazly, AME; Faruk, EM; Hussein, AYA; Mersal, EA; Mogahed, MM; Morsi, AA1
Kang, S1
Fratianni, C; Gonzales, M; Khardori, R; Mamillapali, C1
Gelfand, EW; Hirano, A; Ito, W; Kanehiro, A; Kataoka, M; Nakashima, H; Okada, C; Ono, K; Tanimoto, M; Tanimoto, Y; Yoshida, A1
Bratt, JM; Decile, KC; Giri, SN; Grewal, H; Mansoor, JK; Margolin, SB; Pinkerton, KE; Schelegle, ES; Walby, WF1

Reviews

1 review(s) available for pirfenidone and Asthma

ArticleYear
Immunotherapy in miscellaneous medical disorders Graves ophthalmopathy, asthma, and regional painful syndrome.
    The Medical clinics of North America, 2012, Volume: 96, Issue:3

    Topics: Allergens; Anti-Asthmatic Agents; Antibodies, Anti-Idiotypic; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antioxidants; Asthma; Azathioprine; Benzamides; Complex Regional Pain Syndromes; Cyclosporine; Decompression, Surgical; Etanercept; Glucocorticoids; Graves Ophthalmopathy; Humans; Imatinib Mesylate; Immunoglobulin G; Immunoglobulins, Intravenous; Immunosuppressive Agents; Immunotherapy; Octreotide; Omalizumab; Orbit; Piperazines; Pyridones; Pyrimidines; Radiotherapy Dosage; Receptors, Tumor Necrosis Factor; Risk Factors; Rituximab; Selenium

2012

Other Studies

4 other study(ies) available for pirfenidone and Asthma

ArticleYear
Modeling the Effects of Cypermethrin Toxicity on Ovalbumin-Induced Allergic Pneumonitis Rats: Macrophage Phenotype Differentiation and p38/STAT6 Signaling Are Candidate Targets of Pirfenidone Treatment.
    Cells, 2023, 03-24, Volume: 12, Issue:7

    Topics: Alveolitis, Extrinsic Allergic; Animals; Asthma; Dexamethasone; Inflammation; Macrophages; Male; Ovalbumin; p38 Mitogen-Activated Protein Kinases; Phenotype; Pneumonia; Rats; Rats, Wistar

2023
2014 American Thoracic Society International Conference.
    The Lancet. Respiratory medicine, 2014, Volume: 2, Issue:7

    Topics: Acetylcysteine; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Humanized; Asthma; Congresses as Topic; Eosinophilia; Expectorants; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Idiopathic Pulmonary Fibrosis; Indoles; Lung Neoplasms; Protein Kinase Inhibitors; Pulmonary Disease, Chronic Obstructive; Pyridones; Respiratory Distress Syndrome

2014
Pirfenidone modulates airway responsiveness, inflammation, and remodeling after repeated challenge.
    American journal of respiratory cell and molecular biology, 2006, Volume: 35, Issue:3

    Topics: Allergens; Animals; Anti-Inflammatory Agents, Non-Steroidal; Asthma; Bronchial Hyperreactivity; Bronchoalveolar Lavage Fluid; Cell Proliferation; Cytokines; Eosinophils; Goblet Cells; Hyperplasia; Immunoglobulin E; Interleukin-13; Interleukin-4; Interleukin-5; Leukocytes, Mononuclear; Lymphocytes; Mice; Mice, Inbred BALB C; Ovalbumin; Platelet-Derived Growth Factor; Pyridones; Transforming Growth Factor beta; Transforming Growth Factor beta1

2006
Influence of pirfenidone on airway hyperresponsiveness and inflammation in a Brown-Norway rat model of asthma.
    Pulmonary pharmacology & therapeutics, 2007, Volume: 20, Issue:6

    Topics: Animals; Anti-Inflammatory Agents; Asthma; Bronchi; Bronchial Hyperreactivity; Bronchial Provocation Tests; Collagen; Disease Models, Animal; Inflammation; Lung; Male; Mucins; Muscle, Smooth; Ovalbumin; Pyridones; Random Allocation; Rats; Rats, Inbred BN; Respiratory Mucosa; Transforming Growth Factor beta

2007